Fairway Wealth’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$171K Buy
+405
New +$161K 0.04% 77
2026
Q1
– Sell
-19
Closed -$6.22K – 196
2025
Q4
$6.22K Buy
+19
New +$6.03K ﹤0.01% 167
2025
Q2
– Sell
-37
Closed -$11.5K – 183
2025
Q1
$11.5K Sell
37
-270
-88% -$79.7K ﹤0.01% 155
2024
Q4
$80K Buy
+307
New +$91.1K 0.04% 81
2024
Q3
– Sell
-66
Closed -$20.6K – 121
2024
Q2
$20.6K Buy
+66
New +$19.4K 0.01% 93

Other funds holding AMGN

Fairway Wealth's AMGN Position: Q3 2026 in Review

Fairway Wealth opened a new position in Amgen (AMGN) in Q3 2026: 405 shares worth $171K. The stake represents 0.04% of the portfolio and ranks #77 among its holdings. This is a return to the name: Fairway Wealth previously reported a position in AMGN as recently as Q4 2025.

Fairway Wealth first reported a position in AMGN in Q2 2024 and has held it in 5 quarters since. 3,275 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

  • Fairway Wealth held 405 shares of Amgen worth $171K as of Q3 2026.
  • Amgen was a new Fairway Wealth position in Q3 2026.
  • Amgen made up 0.04% of Fairway Wealth's portfolio in Q3 2026, its #77 holding.
  • Fairway Wealth first reported a position in Amgen in Q2 2024 and has held it in 5 quarters since.
  • 3,275 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on Fairway Wealth's 13F filing for Q3 2026, filed 30 Oct 2026.